| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |